Suchergebnisse - "Guan, Xiuwen"

PubPharm (7)

1

Survival benefit and biomarker analysis of pyrotinib or pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer : a pooled analysis of two phase I studies

enthalten in: Biomarker research | 2023

von Guan, X. | Ma, F. | Li, Q. | +9

2

Survival benefit and biomarker analysis of pyrotinib or pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer: a pooled analysis of two phase I studies

enthalten in: Biomarker Research | 2023

von Guan, X. | Ma, F. | Li, Q. | +9

3

Real world initial palliative treatment patterns and clinical outcomes in premenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer : A study of the National Cancer Center, China

enthalten in: Breast (Edinburgh, Scotland) | 2022

von Li, Y. | Mo, H. | Guan, X. | +14

4

Incidence, risk factors and survival of patients with brain metastases at initial metastatic breast cancer diagnosis in China

enthalten in: Breast (Edinburgh, Scotland) | 2021

von Li, Y. | Li, Q. | Mo, H. | +16

5

Polymorphisms of MTHFR and TYMS predict capecitabine-induced hand-foot syndrome in patients with metastatic breast cancer

enthalten in: Cancer communications (London, England) | 2019

von Lin, S. | Yue, J. | Guan, X. | +11

6

Polymorphisms of MTHFR and TYMS predict capecitabine-induced hand-foot syndrome in patients with metastatic breast cancer

enthalten in: Cancer communications | 2019

von Lin, S. | Yue, J. | Guan, X. | +11

7

Polymorphisms of MTHFR and TYMS predict capecitabine-induced hand-foot syndrome in patients with metastatic breast cancer

enthalten in: Chinese journal of cancer | 2019

von Lin, S. | Yue, J. | Guan, X. | +11

1
[1]